Gene · 3046
Papers4,524
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,524
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hepatitis B Virus-related Membranous Nephropathy with Crescentic Formation in an Inactive Carrier of Positive Hepatitis B Surface Antigen with Undetectable DNA under Anti-viral Treatment. | Intern Med | 2024 | 37225490 | PubTator, text mining | PubMed |
| Impact of viral hepatitis therapy in multiple myeloma and other monoclonal gammopathies linked to hepatitis B or C viruses. | Haematologica | 2024 | 37199121 | PubTator, text mining | PubMed |
| Internalization of cell-derived microparticles triggers endothelial pro-inflammatory responses. | Asian Pac J Allergy Immunol | 2024 | 33865295 | PubTator, text mining | PubMed |
| [Role of hepatitis B virus e protein and core protein in hepatocarcinogenesis]. | Virologie (Montrouge) | 2023 | 38239027 | PubTator, text mining | PubMed |
| Depression among Patients with Chronic Hepatitis B: A Cross-sectional Study in a Tertiary Hospital of Bangladesh. | Euroasian J Hepatogastroenterol | 2023 | 38222954 | PubTator, text mining | PubMed |
| CRISPR/Cas9 as a New Antiviral Strategy for Treating Hepatitis Viral Infections. | Int J Mol Sci | 2023 | 38203503 | PubTator, text mining | PubMed |
| Glutathione Non-Covalent Binding Sites on Hemoglobin and Major Glutathionylation Target betaCys93 Are Conservative among Both Hypoxia-Sensitive and Hypoxia-Tolerant Mammal Species. | Int J Mol Sci | 2023 | 38203223 | PubTator, text mining | PubMed |
| [Analysis of hemoglobin variants in Tianjin City and neighboring areas]. | Zhonghua Yu Fang Yi Xue Za Zhi | 2023 | 38186169 | PubTator, text mining | PubMed |
| Novel stem cell technologies are powerful tools to understand the impact of human factors on Plasmodium falciparum malaria. | Front Cell Infect Microbiol | 2023 | 38173794 | PubTator, text mining | PubMed |
| Scalable noninvasive amplicon-based precision sequencing (SNAPseq) for genetic diagnosis and screening of β-thalassemia and sickle cell disease using a next-generation sequencing platform. | Front Mol Biosci | 2023 | 38152111 | PubTator, text mining | PubMed |
| Gene-Editing and RNA Interference in Treating Hepatitis B: A Review. | Viruses | 2023 | 38140636 | PubTator, text mining | PubMed |
| HBV Vaccines: Advances and Development. | Vaccines (Basel) | 2023 | 38140265 | PubTator, text mining | PubMed |
| Point-of-Care Testing for Hepatitis Viruses: A Growing Need. | Life (Basel) | 2023 | 38137872 | PubTator, text mining | PubMed |
| In Silico Structural Protein Evaluation of the Phenylalanine Hydroxylase p.(Tyr77His) Variant Associated with Benign Hyperphenylalaninemia as Identified through Mexican Newborn Screening. | Children (Basel) | 2023 | 38136067 | PubTator, text mining | PubMed |
| A small molecule iCDM-34 identified by in silico screening suppresses HBV DNA through activation of aryl hydrocarbon receptor. | Cell Death Discov | 2023 | 38135680 | PubTator, text mining | PubMed |
| Efficacy and safety of tenofovir alafenamide in patients with chronic hepatitis B exhibiting suboptimal response to entecavir. | World J Clin Cases | 2023 | 38130795 | PubTator, text mining | PubMed |
Pan-cancer analysis identifies protein arginine methyltransferases PRMT1 and PRMT5 and their related signatures as markers associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma. | Heliyon | 2023 | 38125466 | PubTator, text mining | PubMed |
| Bridging the gaps in newborn screening programmes: Challenges and opportunities to detect haemoglobinopathies in Africa. | Afr J Lab Med | 2023 | 38116518 | PubTator, text mining | PubMed |
| The first Chinese with Hb Chile leading to chronic anemia and methemoglobinemia: a case report. | BMC Pediatr | 2023 | 38110882 | PubTator, text mining | PubMed |
| Noncoding function of super enhancer derived mRNA in modulating neighboring gene expression and TAD interaction. | bioRxiv | 2023 | 38105946 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3046/papers?page=12